Evidence map›Paper›PMID 38585208›Full record

ArticleEuropean urology open science2024

How Can We Improve Patient-Clinician Communication for Men Diagnosed with Prostate Cancer?

Katharina Beyer, Ailbhe Lawlor, Sebastiaan Remmers, Carla Bezuidenhout, Juan Gómez Rivas, Lionne D F Venderbos, Emma J Smith, Giorgio Gandaglia, Steven MacLennan, Sara J MacLennan and 10 more

Abstract read
In one paragraph

Article in European urology open science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Katharina BeyerDepartment of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands.
Ailbhe LawlorTranslational Oncology and Urology Research, King's College London, London, UK.
Sebastiaan RemmersDepartment of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands.
Carla BezuidenhoutEuropean Association of Urology Guidelines Office, Arnhem, The Netherlands.
Juan Gómez RivasDepartment of Urology, Clínico San Carlos University Hospital, Madrid, Spain.
Lionne D F VenderbosDepartment of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands.
Emma J SmithEuropean Association of Urology Guidelines Office, Arnhem, The Netherlands.
Giorgio GandagliaDepartment of Urology, Division of Experimental Oncology, Urological Research Institute, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Steven MacLennanAcademic Urology Unit, University of Aberdeen, Aberdeen, Scotland.
Sara J MacLennanAcademic Urology Unit, University of Aberdeen, Aberdeen, Scotland.
Anders BjartellRoyal Liverpool and Broadgreen Hospitals NHS Trust, Liverpool, UK.
Alberto BrigantiDepartment of Urology, Division of Experimental Oncology, Urological Research Institute, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Philip CornfordDepartment of Translational Medicine, Lund University, Lund, Sweden.
Susan Evans-AxelssonMedical Affairs Oncology, Bayer AB, Stockholm, Sweden.
Maria J RibalEuropean Association of Urology Guidelines Office, Arnhem, The Netherlands.
James N'DowEuropean Association of Urology Guidelines Office, Arnhem, The Netherlands.
Erik BriersPatient advocate, Hasselt, Belgium.
Monique J RoobolDepartment of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands.
Mieke Van HemelrijckTranslational Oncology and Urology Research, King's College London, London, UK.
PIONEER Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and objective: The ability of health care professionals to communicate with patients compassionately and effectively is crucial for shared decision-making, but little research has investigated patient-clinician communication. As part of PIONEER-an international Big Data Consortium led by the European Association of Urology to answer key questions for men with prostate cancer (PCa), funded through the IMI2 Joint Undertaking under grant agreement 777492- we investigated communication between men diagnosed with PCa and the health care professional(s) treating them across Europe. Methods: We used the European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire-Communication 26, which was shared via the PIONEER and patient organisations on March 11, 2022. We sought men who spoke French, Italian, Spanish, German, Dutch, or English who were diagnosed with PCa and were undergoing or had already received treatment for their PCa. Results and limitations: A total of 372 men reported that they communicated with their clinician during either the diagnostic or the treatment period. Overall, the majority of participants reported positive experiences. However, important opportunities to enhance communication were identified, particularly with regard to correcting misunderstandings, understanding the patient's preferred approach to information presentation, addressing challenging questions, supporting the patient's comprehension of information, attending to the patient's emotional needs, and assessing what information had already been given to patients about their disease and treatment, and how much of it was understood. Conclusions and clinical implications: These results help us to identify gaps and barriers to shared treatment decision making. This knowledge will help devise measures to improve patient-health care professional communication in the PCa setting. Patient summary: As part of the PIONEER initiative, we investigated the communication between men diagnosed with prostate cancer and their health care professionals across Europe. A total of 372 men from six different countries participated in the study. Most participants reported positive experiences, but areas where communication could be improved were identified. These included addressing misunderstandings, tailoring the presentation of information to the patient's preferences, handling difficult questions, supporting emotional needs, and assessing the patient's understanding of their diagnosis and treatment.

Identifiers

PMID38585208
PMCPMC10998269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.